Evidence map›Paper›PMID 41852001›Full record

ArticleArchives of Iranian medicine2025

Spatiotemporal Epidemiology of Female Thyroid Cancer: A Retrospective Population-Based Registry Study in the Hamadan Province, Iran (2010-2019).

Erfan Ayubi, Shiva Borzouei, Sharareh Niksiar, Salman Khazaei

Abstract read
In one paragraph

Article in Archives of Iranian medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Erfan AyubiSocial Determinants of Health Research Center, Institute of Health Sciences and Technology, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID 0000-0002-8829-9304
Shiva BorzoueiDepartment of Endocrinology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Sharareh NiksiarHamadan Cancer Registry, Hamadan University of Medical Sciences, Hamadan, Iran.
Salman KhazaeiResearch Center for Health Sciences, Institute of Health Sciences and Technology, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID 0000-0001-5918-2310

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThyroid cancer (TC) incidence varies regionally in Iran, with a notable increase observed in females. However, region-specific spatiotemporal epidemiological data are limited. This study aimed to quantify the spatiotemporal trends and geographic clustering of female TC in the Hamadan province, western Iran, from 2010 to 2019.

methodsFemale TC cases from the Hamadan province were obtained from the population-based cancer registry. County-level standardized incidence ratios (SIRs) were calculated to adjust for differences in population size, and were smoothed using a hierarchical Bayesian spatial smoothing model that accounts for spatial and temporal dependence. Temporal trends were analyzed using joinpoint regression. Spatiotemporal clusters were identified using space-time scan statistics.

resultsThe incidence of female TC showed an average annual increase of 14.5% (Average annual percent change [AAPC]: 14.5, 95% confidence interval: 4.7 to 25.3;

conclusionThis study revealed significant spatiotemporal heterogeneity in female TC incidence in the Hamadan province. Identification of high-risk clusters provides an evidence base for targeted preventive measures and health resource allocation.

Indexed as

Thyroid NeoplasmsAdultAgedBayes TheoremFemaleHumansIncidenceIranMiddle AgedRegistriesRetrospective StudiesSpatio-Temporal AnalysisHamadanIranSpatiotemporal patternThyroid cancerWomen

Identifiers

PMID41852001
PMCPMC13000320

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.